Senseonics Holdings (SENS) Profit After Tax Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -197.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -197.84% |
| Dec 31, 2025 | -56.09% |
| Sep 30, 2025 | 31.36% |
| Jun 30, 2025 | -28.85% |
| Mar 31, 2025 | -29.35% |
| Dec 31, 2024 | -29.73% |
| Sep 30, 2024 | -36.77% |
| Jun 30, 2024 | 51.72% |
| Mar 31, 2024 | 57.71% |
| Dec 31, 2023 | 44.69% |
| Sep 30, 2023 | -0.95% |
| Jun 30, 2023 | -39.55% |
| Mar 31, 2023 | 26.64% |
| Dec 31, 2022 | 32.46% |
| Sep 30, 2022 | -45.77% |
| Jun 30, 2022 | 74.94% |
| Mar 31, 2022 | 70.46% |
| Dec 31, 2021 | 138.30% |
| Sep 30, 2021 | 49.57% |
| Jun 30, 2021 | -77.04% |
| Mar 31, 2021 | -123.75% |
| Dec 31, 2020 | -84.15% |
| Sep 30, 2020 | -10.47% |
| Jun 30, 2020 | 15.32% |
| Mar 31, 2020 | -48.25% |
| Dec 31, 2019 | -52.89% |
| Sep 30, 2019 | -21.44% |
| Jun 30, 2019 | -37.86% |
| Mar 31, 2019 | -37.83% |
| Dec 31, 2018 | 4.53% |
| Sep 30, 2018 | -54.86% |
| Jun 30, 2018 | -65.37% |
| Mar 31, 2018 | -57.57% |
| Dec 31, 2017 | -1,735.89% |
| Sep 30, 2017 | -830.10% |
| Jun 30, 2017 | -1,518.42% |